Tamoxifen Citrate
24,90 €
New product
Specifications:
Company: Hilma Biocare
Active Half-life (Days): 5 – 7 Days
Group: Selective estrogen receptor modulator (SERM) / Antiestrogen
Subgroup: Oral/tablets
Dosage: 20 mg per tab
Application (Men): 20 mg/day
Product pack: 50 tab.
Content (active): Tamoxifen citrate
Retains water: No
Aromatization: No
More info
Product Description:
Tamoxifen exhibits a dual spectrum of pharmacological action, functioning as both an estrogen antagonist and agonist in various tissues. Originally introduced in 1961 by ICI (Asta Zenaca), Tamoxifen Citrate has demonstrated remarkable efficacy in breast cancer treatment and mitigating estrogenic adverse reactions resulting from anabolic steroid use for decades. The drug finds utility in treating ovarian, endometrial, prostate, and kidney cancer, as well as conditions such as melanoma and soft tissue sarcomas in the presence of estrogen receptors in the tumor. Tamoxifen Citrate, belonging to the Selective Estrogen Receptor Modulator (SERM) group, is utilized by bodybuilders as part of post-cycle therapy (PCT).
Effects:
Tamoxifen citrate is highly effective during PCT, enabling athletes to restore normal testosterone levels and recover sex drive suppressed by the use of other steroids.
Side-Effects:
Common adverse reactions associated with Tamoxifen citrate include headache, insomnia, nausea, gastrointestinal disorders, fatigue, and leg cramps.
Stacking:
Tamoxifen citrate can be stacked with clomiphene during post-cycle therapy (PCT).
Download Tamoxifen Citrate Product Test
